1. Background
2. Objectives
3. Patient and Methods
3.1. Participants
3.2. Main Trials
3.3. Test Meals
3.4. Blood Collection and Analysis
3.5. Statistical Analysis
4. Results
4.1. Fasting Oxidative Stress Markers on Days 1 and 2
| Parameters | M | A | P Value (Trial) |
|---|---|---|---|
| BAP, μM | 0.931 | ||
| Sitting | 2669 ± 69 | 2574 ± 77 | |
| Standing | 2608 ± 62 | 2559 ± 101 | |
| Exercise | 2657 ± 55 | 2572 ± 61 | |
| SOD, U/mL | 0.015 | ||
| Sitting | 12.8 ± 1.5 | 14.5 ± 1.5 | |
| Standing | 14.0 ± 1.3 | 14.3 ± 1.3 | |
| Exercise | 13.5 ± 1.3 | 12.2 ± 1.3 | |
| CAT, U/mL | 0.556 | ||
| Sitting | 51.3 ± 4.2 | 58.2 ± 5.6 | |
| Standing | 49.9 ± 3.5 | 57.6 ± 5.4 | |
| Exercise | 54.3 ± 4.5 | 66.2 ± 5.7 |
a Data are presented as mean ± SE, and N = 15.
b M, morning on days one; A, afternoon on days one.
c Data were analyzed using one-factor ANOVA.
| Parameter | 0 Hour | 2 Hours | 4 Hours | 6 Hours | P Value | ||
|---|---|---|---|---|---|---|---|
| Trial | Time | Trial × Time | |||||
| BAP, μM | 0.882 | 0.001 | 0.594 | ||||
| Sitting | 2600 ± 51 | 2387 ± 64 | 2436 ± 72 | 2459 ± 72 | |||
| Standing | 2621 ± 63 | 2332 ± 67 | 2440 ± 84 | 2527 ± 68 | |||
| Exercise | 2643 ± 70 | 2402 ± 61 | 2408 ± 75 | 2507 ± 54 | |||
| SOD, U/mL | 0.664 | 0.370 | 0.548 | ||||
| Sitting | 13.7 ± 1.2 | 14.1 ± 1.5 | 13.3 ± 1.3 | 13.7 ± 1.5 | |||
| Standing | 13.5 ± 1.4 | 14.2 ± 1.3 | 14.2 ± 1.4 | 13.8 ± 1.4 | |||
| Exercise | 13.1 ± 1.1 | 13.7 ± 1.2 | 13.4 ± 1.2 | 14.4 ± 1.2 | |||
| CAT, U/mL | 0.168 | 0.010 | 0.143 | ||||
| Sitting | 49.3 ± 5.7 | 53.6 ± 3.5 | 59.9 ± 4.7 | 64.2 ± 5.1 | |||
| Standing | 50.5 ± 3.0 | 64.7 ± 5.5 | 62.4 ± 4.5 | 56.6 ± 3.9 | |||
| exercise | 55.5 ± 5.2 | 65.4 ± 6.5 | 71.4 ± 6.9 | 60.0 ± 4.8 | |||
a Data are presented as mean ± SE, and N = 15.
b Data were analyzed using two-factor ANOVA.
4.2. The Change of Oxidative Stress Markers on Day 1
4.3. Postprandial Oxidative Stress Markers on Day 2
(A), plasma thiobarbituric acid reactive substances (TBARS) (B), activity of glutathione peroxidase (GPX) (C), and concentrations of plasma thioredoxin (TRX) (D) measured on days one and two during the sitting, standing, and exercise trials (n = 15). Data were presented as means ± standard error (SE). M, morning on day one; A, afternoon on day one. The black rectangles indicate the times when the test meals were consumed. Data were analysed using two-factor ANOVA. The main effect of trials (d-ROMs, P = 0.352; TBARS, P = 0.850; GPX, P = 0.228; TRX, P = 0.904), time (d-ROMs, P = 0.116; TBARS, P = 0.001; GPX, P = 0.083; TRX, P = 0.738), and trials × time interaction (d-ROMs, P = 0.006; TBARS, P = 0.093; GPX, P = 0.017; TRX, P = 0.049).
